Throughout her 16-week treatment on Lastisse, Danes was photographed at different angles to demonstrate her lash growth. The gallery is posted on the Latisse site and none of the photos have been retouched.
Danes said she became the latest “Latisse girl” because she was curious about the product. “The more I learned about Latisse, the more impressed I was. I’ve never used a product that actually affected real physical change,” she said.
In 2001, Allergan developed a glaucoma treatment called Lumigan, and a side effect was discovered—patients began growing longer, fuller lashes. This led Allergan to study the active ingredient in this other product, and after a clinical trial, Latisse was born and earned FDA approval in December 2008.
During research of Latisse, doctors reported on average:
25 percent increase in eyelash length
106 percent increase in eyelash fullness
18 percent darkening of the eyelashes
The effects of Latisse are not permanent, so you have to keep using it, as the eyelashes will return to normal if you stop using Latisse. Advancements in Dermatology offers Lastisse; call for more information and special introductory pricing. You can sign up for Latisse Lash Perks to get a $20 rebate on Latisse. (images via www.latisse.com)
A new generation peel for all skin types to improve skin tone and texture. Great for reversing sun damage and signs of aging while stimulating collagen and elastin production. A single Vi Peel will achieve significant repair and add a healthy glow to the skin. It is a true, restorative and painless repair of damaged skin including sun damage and acne.
The VI Peel addresses skin problems at the cellular level to help erase fine lines and wrinkles, shrink enlarged pores and build collagen. It is effective in practically eliminating hyper pigmentation including melasma, the most difficult pigmentation issue to address. The Vi Peel also provides excellent results for patients with acne.
The skin peeling associated with the VI Peel is a light, fluffy peel that begins on the third day and is generally finished by the end of day four. The peeling is easily hidden by moisturizer and in some cases is virtually invisible.
Rejuvenize Peel:
An advanced formulation of peeling agents, with a built-in anti-irritant and penetration enhancer that provides controlled exfoliation of the uppermost damaged layers of the skin to reveal fresher and healthier skin.
Provides predictable results with minimal down time.
Effective for use o skin with sun damage, melasma, pigmentary changes and acne scarring
Noticeable improvement with just one peel
Recommended for Skin types I-VI
Can be used on skin types V-VI after the patient has established tolerability to Vitalize Peel, or with physician consent
Well tolerated with minimal “down time”
Easy to use (does not require timing or neutralization)
A novel synthetic surfactant, Isoceteth-20, creates more uniform peeling while controlling penetration of salicylic acid, and therefore reduces skin irritation associated with the stronger chemical peels without diminishing peeling effect
The philosophy of SkinMedica is that everyone deserves to have naturally radiant skin. Each SkinMedica product is backed by years of research on the skin’s healing ability. Restorative ingredients such as retinol, Vitamin C, Vitamin E and their patented TNS growth factors make these products an effective part of your anti-aging and skin care regimen.
From the inventor of the Sonicare toothbrush – The micro-massage action of the Clarisonic skincare brush makes 300 movements per second to gently loosen dirt and oil. Apparently, your hands just aren’t going to cut it anymore when it comes to facial cleansing – technology to the rescue!
9. Omnilux “New U” and “Clear U” Handheld LED light technology
The new-U is designed to treat periorbital wrinkles and improve skin clarity, while the clear-U is designed to reduce inflammation and acne.
Now if they could only make my iPhone do this, we’d really be in business!
8. gloMinerals Lash Thickener and Conditioner
While you may not realize the same effects as a prescription product like Latisse, the gloLash thickener and conditioner is said to help lashes “grow to their potential” with an exclusive antioxidant blend of vitamins A, C, and E.
What is Clarisonic? If you haven’t heard, Clarisonic is a “sonic” skin cleansing system that removes dirt and oil much better than typical methods of skin cleansing.
From the website:
Clarisonic is the sonic technology proven to gently yet effectively loosen dirt and oil to clear your pores. The Clarisonic Skin Cleansing Brush uses a patented sonic frequency of more than 300 movements per second to clean, soften and smooth your skin. In just 60 seconds a day, the Clarisonic micro-massage action cleans more than twice as effectively as manual cleansing.
Drugs in the United States often make their way to the market inadvertently, becoming hugely popular for uses that were never intended; such is the case with Allergan’s new offering, Latisse. The hot new eyelash enhancer was born out of a group of popular medications called topical prostaglandins, drugs frequently used to decrease intra-ocular pressure in glaucoma patients.
What was first labeled a complication or side effect of using these topical agents was hypertrichosis, a condition characterized by darkening, thickening, and lengthening of the eyelashes.
Allergan offered the topical prostaglandin Lumigan in 2001, a drug that contained the active ingredient bimatoprost. Two important precursors to Latisse occurred after the FDA gave clearance for Lumigan.
Jan Marini Skin Research Inc had over $2 million worth of product seized by the Food and Drug Administration. The product, Age Intervention Eyelash, evidently contained bimatoprost, which was unapproved for cosmetic use at the time. Allergan later filed a patent infringement suit against Jan Marini and several other companies that had tried to market bimatoprost in their eyelash enhancing drugs.
Some doctors started prescribing Lumigan off-label to enhance eyelashes. Knowing the desirable side effects it could produce. But Lumigan was not formulated for cosmetic use and many believed more research was needed to confirm the safety of topical prostaglandins for cosmetic use.
Clinical trials and further research is exactly what Alllergan Inc did. In one early study, 278 healthy adults with minimal to moderate eyelash prominence applied bimatoprost or a placebo to their lash line. The results were favorable; researchers observed that the average patient’s eyelashes were 25 percent longer, 106 percent fuller, and 18 percent darker, while only 3.6 percent experienced itchy eyes and redness, and only 2.9 percent experienced skin hyperpigmentation.
Latisse received FDA approval late last year for the treatment of inadequate eyelashes. Allergan now owns the patent on use of bimatoprost for eyelash enhancement.
The recently published April ’09 issue of People featured “312 easy style updates” and one just happened to be Allergan’s new eyelash enhancement drug, Latisse.
Latisse is FDA approved for the treatment of hypotrichosis, i.e. inadequate eyelashes. It is available by prescription only. If you are interested or would like more information, contact our Minneapolis dermatology office.
On this episode of ‘The Doctors daytime TV show, dermatologist Jessica Wu showcases the new eyelash enhancement drug, Latisse.
Dr. Wu claims that Latisse can give you “crazy long spidery lashes” in about 4 months. You apply Latisse to the base of upper eyelashes once each night, “just like liquid eyeliner.” According to Dr. Wu, the results should yield lashes that are 25 percent longer and 100 percent thicker!
See the video for a before & after photo; it is quite impressive. If you are interested in learning more about Latisse in Minneapolis, contact our office.
At a star-studded Hollywood charity event last March, Botox manufacturer Allergan Inc. announced the ‘Latisse Wishes” campaign, and pledged 1 million dollars to charity. Big name celebrities like Mandy Moore, Brooke Shields and Marisa Tomei showed to pledge their support for Make-A-Wish, the non-profit organization known for granting the wishes of suffering children.
Latisse is Allergan’s latest offering and the first drug to be approved by the FDA for the treatment of hypotrichosis, a condition characterized by inadequate eyelashes. The Latisse Wishes campaign was launched by Allergan with a $500,000 initial contribution to Make-A-Wish.
Hollywood beauty expert and participant Anastasia Soare enthusiastically expressed her support, saying “I constantly work to help make women’s beauty wishes come true, and now we can help children’s wishes come true through the LATISSE Wishes campaign.”
It’s no coincidence that the Make-A-Wish foundation was chosen as a beneficiary for Allergan’s campaign; the superstitious “blowing on an eyelash to make a wish come true” provides a clever marketing strategy, backed by philanthropy.
The campaign is encouraging consumers to help double the donation amount by visiting www.Latisse.com and registering their support. From now until the end of the year, Allergan will donate 5 dollars for each new registration, up to one million dollars.
Latisse, which is the first and only prescription treatment approved by the FDA to grow lashes longer, fuller and darker, recently unveiled before and after photos of its latest celebrity spokesperson, actress Claire Danes. She follows in footsteps of Brooke Shields as a spokesmodel for the lash grower.
From the inventor of the Sonicare toothbrush – The micro-massage action of the Clarisonic skincare brush makes 300 movements per second to gently loosen dirt and oil. Apparently, your hands just aren’t going to cut it anymore when it comes to facial cleansing – technology to the rescue!
The 
While you may not realize the same effects as a prescription product like Latisse, the 
Drugs in the United States often make their way to the market inadvertently, becoming hugely popular for uses that were never intended; such is the case with Allergan’s new offering, 
The recently published April ’09 issue of People featured “312 easy style updates” and one just happened to be Allergan’s new eyelash enhancement drug, 
